Terms: = Breast cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Prognosis
8 results:
1. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through chd4 degradation and Wnt/β-catenin pathway inhibition.
Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
[TBL] [Abstract] [Full Text] [Related]
2. Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review.
Palmisciano P; Chen AL; Sharma M; Bin-Alamer O; Ferini G; Umana GE; Aoun SG; Haider AS
Anticancer Res; 2022 Jul; 42(7):3251-3259. PubMed ID: 35790288
[TBL] [Abstract] [Full Text] [Related]
3. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.
Ho AY; Barker CA; Arnold BB; Powell SN; Hu ZI; Gucalp A; Lebron-Zapata L; Wen HY; Kallman C; D'Agnolo A; Zhang Z; Flynn J; Dunn SA; McArthur HL
Cancer; 2020 Feb; 126(4):850-860. PubMed ID: 31747077
[TBL] [Abstract] [Full Text] [Related]
4. Over-Expression of chd4 Is an Independent Biomarker of Poor prognosis in Patients with Rectal cancers Receiving Concurrent Chemoradiotherapy.
Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of inflammatory breast cancer: a vibrational microspectroscopy and imaging approach at the cellular and tissue level.
Mohamed HT; Untereiner V; Proult I; Ibrahim SA; Götte M; El-Shinawi M; Mohamed MM; Sockalingum GD; Brézillon S
Analyst; 2018 Dec; 143(24):6103-6112. PubMed ID: 30468236
[TBL] [Abstract] [Full Text] [Related]
6. chd4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
Luo CW; Wu CC; Chang SJ; Chang TM; Chen TY; Chai CY; Chang CL; Hou MF; Pan MR
Exp Cell Res; 2018 Feb; 363(1):65-72. PubMed ID: 29305962
[TBL] [Abstract] [Full Text] [Related]
7. Salivary gland-like breast carcinomas: An infrequent disease.
Sherwell-Cabello S; Maffuz-Aziz A; Ríos-Luna NP; Bautista-Piña V; Rodríguez-Cuevas S
Pathol Res Pract; 2016 Nov; 212(11):1034-1038. PubMed ID: 27667558
[TBL] [Abstract] [Full Text] [Related]
8. Extrapulmonary small cell cancer: a Canadian province's experience.
Haider K; Shahid RK; Finch D; Sami A; Ahmad I; Yadav S; Alvi R; Popkin D; Ahmed S
Cancer; 2006 Nov; 107(9):2262-9. PubMed ID: 16998932
[TBL] [Abstract] [Full Text] [Related]
